CN104605340A - Euglena oral liquid and production method thereof - Google Patents
Euglena oral liquid and production method thereof Download PDFInfo
- Publication number
- CN104605340A CN104605340A CN201410747138.8A CN201410747138A CN104605340A CN 104605340 A CN104605340 A CN 104605340A CN 201410747138 A CN201410747138 A CN 201410747138A CN 104605340 A CN104605340 A CN 104605340A
- Authority
- CN
- China
- Prior art keywords
- euglena
- oral liquid
- vitamin
- raw material
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000195620 Euglena Species 0.000 title claims abstract description 47
- 239000007788 liquid Substances 0.000 title claims abstract description 15
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 6
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 20
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 20
- 239000000843 powder Substances 0.000 claims abstract description 20
- 239000002994 raw material Substances 0.000 claims abstract description 17
- 230000001954 sterilising effect Effects 0.000 claims abstract description 13
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 10
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 10
- 210000002969 egg yolk Anatomy 0.000 claims abstract description 10
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 10
- 238000000227 grinding Methods 0.000 claims abstract description 10
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 10
- 239000011718 vitamin C Substances 0.000 claims abstract description 10
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 10
- 229940046009 vitamin E Drugs 0.000 claims abstract description 10
- 239000011709 vitamin E Substances 0.000 claims abstract description 10
- 239000002002 slurry Substances 0.000 claims abstract description 4
- 238000003860 storage Methods 0.000 claims abstract description 4
- 238000011049 filling Methods 0.000 claims description 12
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 12
- 238000000265 homogenisation Methods 0.000 claims description 12
- 230000007062 hydrolysis Effects 0.000 claims description 12
- 238000006460 hydrolysis reaction Methods 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- 230000008569 process Effects 0.000 claims description 9
- 238000004140 cleaning Methods 0.000 claims description 6
- 238000004659 sterilization and disinfection Methods 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 238000007689 inspection Methods 0.000 claims description 4
- 108010059892 Cellulase Proteins 0.000 claims description 3
- 238000003556 assay Methods 0.000 claims description 3
- 229940106157 cellulase Drugs 0.000 claims description 3
- 238000005202 decontamination Methods 0.000 claims description 3
- 230000003588 decontaminative effect Effects 0.000 claims description 3
- 239000003651 drinking water Substances 0.000 claims description 3
- 235000020188 drinking water Nutrition 0.000 claims description 3
- 238000002386 leaching Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 230000006378 damage Effects 0.000 abstract description 10
- 230000000694 effects Effects 0.000 abstract description 5
- 230000007246 mechanism Effects 0.000 abstract description 4
- 235000016709 nutrition Nutrition 0.000 abstract description 4
- 230000035764 nutrition Effects 0.000 abstract description 4
- 230000001681 protective effect Effects 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 230000002195 synergetic effect Effects 0.000 abstract 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 abstract 1
- 230000002411 adverse Effects 0.000 abstract 1
- 230000007071 enzymatic hydrolysis Effects 0.000 abstract 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 abstract 1
- 231100000516 lung damage Toxicity 0.000 abstract 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 abstract 1
- 238000002156 mixing Methods 0.000 abstract 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 abstract 1
- 229960002675 xylitol Drugs 0.000 abstract 1
- 235000010447 xylitol Nutrition 0.000 abstract 1
- 239000000811 xylitol Substances 0.000 abstract 1
- 210000004072 lung Anatomy 0.000 description 10
- 208000027418 Wounds and injury Diseases 0.000 description 5
- 208000014674 injury Diseases 0.000 description 5
- 230000036541 health Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 description 1
- 208000030507 AIDS Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 206010012434 Dermatitis allergic Diseases 0.000 description 1
- 206010013082 Discomfort Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 description 1
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000012271 agricultural production Methods 0.000 description 1
- 238000003915 air pollution Methods 0.000 description 1
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 231100000206 health hazard Toxicity 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- -1 lutern Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 235000010930 zeaxanthin Nutrition 0.000 description 1
- 229940043269 zeaxanthin Drugs 0.000 description 1
- 239000001775 zeaxanthin Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Non-Alcoholic Beverages (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention discloses a euglena oral liquid and a production method thereof. Main raw materials comprise vitamin C, vitamin E, euglena slurry, hydrolyzed yolk powder and xylitol powder. The euglena oral liquid is prepared through steps of raw material pretreatment, chopping and grinding, enzymatic hydrolysis, juicing, homogenizing, blending, secondary homogenizing, sterilizing, loading, examination, storage and the like. The euglena oral liquid is reasonable in ratio, definite in efficacy, clear in mechanism, relatively strong in pertinency, substantial in cooperative synergic effects, easy to produce and convenient to take, and fills up market blank. The euglena oral liquid does not have any adverse influence on aspects of color, mouthfeel, stability and the like, and does not bring harm and toxic and side effects to body when being eaten normally. The euglena oral liquid has protective effect and gives full play to nutrition complementation and synergic effects on lung damage caused by haze, and fills up market blank.
Description
technical field:
the present invention relates to health product technology field, be specifically related to a kind of Euglena oral liquid and production method thereof.
Background technology
in recent years, along with the fast development of industrial and agricultural production, transportation are day by day flourishing, the pollution that atmospheric environment is subject to the impact of additional contaminants, particularly Atmospheric particulates makes haze weather get more and more.PM2.5 haze is also called and can enters lung particle, can enter blood by bronchus and alveolar, and interference lung exchanges, and causes the various diseases such as respiratory tract infection, injury of lungs and cancer, the health of harm people.The haze weather damage lungs continued, except reducing trip and outdoor activities, wearing masks, the food of various " clearing lung-heat ", " moistening lung " also comes into vogue.But research finds, " clearing lung-heat " in traditional medicine, refers generally to slow down with the relevant symptom of respiratory tract, such as cough, many, the pharyngeal discomforts of phlegm etc.The health hazard that " injury of lungs " that this " clearing lung-heat ", " moistening lung " conceptually cause with solution air pollution causes is not the same thing completely.
euglena is the microcell algae simultaneously having possessed Plants and Animals two kinds of features.Acellular wall and nutrient balancedly containing 59 kinds of needed by human such as vitamin, mineral nutrition thing, amino acid, unrighted acid, chlorophyll, lutern, zeaxanthin, GABA, the nutrition of needed by human body can be supplemented all sidedly, alleviating recessive hunger, is more efficient natural dietary supplement.The Euglena polysaccharide component that it contains; the activity of useful enzyme in body is promoted while removing the unnecessary materials such as bad cholesterol, neutral fat, heavy metal; adjust stomach, protection liver, purify the blood; also there is abirritation to allergic dermatitis, be applied in the medicine of constipation, stool, cancer, AIDS etc. and control allergic symptom.
on current domestic and international market, various health food, nutrient prime replenisher are a feast for the eyes, emerge in an endless stream.But exact efficacy, mechanism is clearly specifically designed to the health food preventing the injury of lungs caused by haze, still belongs to the market vacancy.
summary of the invention:
object of the present invention provides a kind of injury of lungs caused haze to have the oral liquid of protective effect; particularly a kind of exact efficacy, mechanism are clearly, and the harm caused PM2.5 haze has a kind of Euglena oral liquid and the production method thereof of significantly prevention and improvement result.
the object of the present invention is achieved like this.A kind of Euglena oral liquid, is characterized in that: it is made up of the raw material of following weight proportioning, vitamin C: 1-5 part; Vitamin E: 1-5 part; Euglena is starched: 20-40 part; Hydrolysis yolk powder: 20-40 part; Xylosic alcohol powder: 10-20 part;
wherein the weight proportion of various raw material is, vitamin C: 3 parts; Vitamin E: 3 parts; Euglena is starched: 30 parts; Hydrolysis yolk powder: 30 parts; Xylosic alcohol powder: 15 parts;
technical process is: pretreatment of raw material, chopping grinding, enzymolysis, go out juice, homogeneous, allotment, second homogenate, sterilization, filling, inspection, preserve, concrete operation method follows these steps to successively:
1. pretreatment of raw material: Euglena raw material is picked decontamination, for subsequent use after cleaning;
2. chopping grinding: by the Euglena chopping after cleaning, milled processed;
3. enzymolysis: the complex cellulase adding its weight 0.1-0.5% to the Euglena after grinding, adjust ph is 4.5-5.0, and hydrolysis temperature is 40-50 DEG C, and enzymolysis time is 5-8h;
4. go out juice: in the Euglena after enzymolysis, add its weight 4-5 water doubly, stir, adopt water leaching to obtain Euglena juice;
5. homogeneous: by the process of Euglena juice homogeneous, temperature is 75-80 DEG C, and homogenization pressure is 18-20MPa, obtained Euglena slurry;
6. allocate: by above-mentioned weight proportion, by vitamin C, vitamin E, Euglena is starched, hydrolysis yolk powder, and xylosic alcohol powder, fully mixes with drinking water, obtained mixed liquor;
7. second homogenate: by the process of mixed liquor homogeneous, temperature is 70-75 DEG C, and adopt double-stage homogenization, one-level homogenization pressure is 22-25MPa, and double-stage homogenization pressure is 10-15MPa;
8. sterilization: by the sterilizing 40-60s at temperature 110-115 DEG C of the mixed liquor after above-mentioned second homogenate;
9. filling: the mixed liquor after above-mentioned sterilizing is filling under sterile vacuum environment;
10. check, storage: by above-mentioned filling after finished product, through after the assay was approved, preserve under normal temperature.
beneficial effect of the present invention: reasonable mixture ratio of the present invention, exact efficacy mechanism is clear, and specific aim is stronger, obvious synergy, and is easy to produce, and taking convenience, has filled up the market vacancy; The present invention all without any harmful effect, normally eats in color and luster mouthfeel and stability etc., can not bring harm and toxic and side effect to health.
the present inventor has given full play to nutrition complement, cooperative gain effect to the food that the injury of lungs that haze causes has protective effect, has filled up the market vacancy.
Detailed description of the invention
below in conjunction with specific embodiment, the present invention is further illustrated
embodiment 1:
a kind of Euglena oral liquid, is characterized in that: it is made up of the raw material of following weight proportioning, vitamin C: 1-5 part; Vitamin E: 1-5 part; Euglena is starched: 20-40 part; Hydrolysis yolk powder: 20-40 part; Xylosic alcohol powder: 10-20 part;
wherein the weight proportion of various raw material is, vitamin C: 3 parts; Vitamin E: 3 parts; Euglena is starched: 30 parts; Hydrolysis yolk powder: 30 parts; Xylosic alcohol powder: 15 parts;
technical process is: pretreatment of raw material, chopping grinding, enzymolysis, go out juice, homogeneous, allotment, second homogenate, sterilization, filling, inspection, preserve, concrete operation method follows these steps to successively:
1. pretreatment of raw material: Euglena raw material is picked decontamination, for subsequent use after cleaning;
2. chopping grinding: by the Euglena chopping after cleaning, milled processed;
3. enzymolysis: the complex cellulase adding its weight 0.1-0.5% to the Euglena after grinding, adjust ph is 4.5-5.0, and hydrolysis temperature is 40-50 DEG C, and enzymolysis time is 5-8h;
4. go out juice: in the Euglena after enzymolysis, add its weight 4-5 water doubly, stir, adopt water leaching to obtain Euglena juice;
5. homogeneous: by the process of Euglena juice homogeneous, temperature is 75-80 DEG C, and homogenization pressure is 18-20MPa, obtained Euglena slurry;
6. allocate: by above-mentioned weight proportion, by vitamin C, vitamin E, Euglena is starched, hydrolysis yolk powder, and xylosic alcohol powder, fully mixes with drinking water, obtained mixed liquor;
7. second homogenate: by the process of mixed liquor homogeneous, temperature is 70-75 DEG C, and adopt double-stage homogenization, one-level homogenization pressure is 22-25MPa, and double-stage homogenization pressure is 10-15MPa;
8. sterilization: by the sterilizing 40-60s at temperature 110-115 DEG C of the mixed liquor after above-mentioned second homogenate;
9. filling: the mixed liquor after above-mentioned sterilizing is filling under sterile vacuum environment;
10. check, storage: by above-mentioned filling after finished product, through after the assay was approved, preserve under normal temperature.
Claims (3)
1. an Euglena oral liquid, is characterized in that: it is made up of the raw material of following weight proportioning, vitamin C: 1-5 part; Vitamin E: 1-5 part; Euglena is starched: 20-40 part; Hydrolysis yolk powder: 20-40 part; Xylosic alcohol powder: 10-20 part.
2. a kind of Euglena oral liquid according to claim 1, is characterized in that: wherein the weight proportion of various raw material is, vitamin C: 3 parts; Vitamin E: 3 parts; Euglena is starched: 30 parts; Hydrolysis yolk powder: 30 parts; Xylosic alcohol powder: 15 parts.
3. the production method of the Euglena oral liquid according to claim 1-2, it is characterized in that: technical process is: pretreatment of raw material, chopping grinding, enzymolysis, go out juice, homogeneous, allotment, second homogenate, sterilization, filling, inspection, preserve, concrete operation method follows these steps to successively:
Pretreatment of raw material: Euglena raw material is picked decontamination, for subsequent use after cleaning;
Chopping grinding: by the Euglena chopping after cleaning, milled processed;
Enzymolysis: the complex cellulase adding its weight 0.1-0.5% to the Euglena after grinding, adjust ph is 4.5-5.0, and hydrolysis temperature is 40-50 DEG C, and enzymolysis time is 5-8h;
Go out juice: in the Euglena after enzymolysis, add its weight 4-5 water doubly, stir, adopt water leaching to obtain Euglena juice; Homogeneous: by the process of Euglena juice homogeneous, temperature is 75-80 DEG C, and homogenization pressure is 18-20MPa, obtained Euglena slurry;
Allotment: by above-mentioned weight proportion, by vitamin C, vitamin E, Euglena is starched, hydrolysis yolk powder, and xylosic alcohol powder, fully mixes with drinking water, obtained mixed liquor;
Second homogenate: by the process of mixed liquor homogeneous, temperature is 70-75 DEG C, and adopt double-stage homogenization, one-level homogenization pressure is 22-25MPa, and double-stage homogenization pressure is 10-15MPa;
Sterilization: by the sterilizing 40-60s at temperature 110-115 DEG C of the mixed liquor after above-mentioned second homogenate;
Filling: the mixed liquor after above-mentioned sterilizing is filling under sterile vacuum environment;
Inspection, storage: by above-mentioned filling after finished product, through after the assay was approved, preserve under normal temperature.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410747138.8A CN104605340A (en) | 2014-12-10 | 2014-12-10 | Euglena oral liquid and production method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410747138.8A CN104605340A (en) | 2014-12-10 | 2014-12-10 | Euglena oral liquid and production method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104605340A true CN104605340A (en) | 2015-05-13 |
Family
ID=53140217
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410747138.8A Pending CN104605340A (en) | 2014-12-10 | 2014-12-10 | Euglena oral liquid and production method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104605340A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105661535A (en) * | 2016-04-11 | 2016-06-15 | 姜国辉 | Lung-moistening and inflammation-diminishing composition for preventing haze harm and preparation method thereof |
| CN105725194A (en) * | 2016-02-22 | 2016-07-06 | 北京珍生康业生物科技有限公司 | Membrane-ruptured euglena capsules and preparation method thereof |
| CN105901714A (en) * | 2016-04-27 | 2016-08-31 | 青岛旭能生物工程有限责任公司 | Euglena compound tablet and preparation method thereof |
| CN105901573A (en) * | 2016-04-27 | 2016-08-31 | 青岛旭能生物工程有限责任公司 | Nannochloropsis salina oil powder containing capsule and preparation method thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH02265458A (en) * | 1989-04-04 | 1990-10-30 | Nikken Food Kk | Aging control food |
| CN101233893A (en) * | 2007-11-19 | 2008-08-06 | 广东海洋大学 | Method for preparing sargasso ice-cream |
| CN101449827A (en) * | 2008-12-29 | 2009-06-10 | 江西品生源生物工程有限责任公司 | Green algae oral liquid production method |
| CN101473983A (en) * | 2008-11-10 | 2009-07-08 | 广东海洋大学 | Method for producing compound beverage with pineapple and gulfweed juices |
| CN104095182A (en) * | 2014-06-16 | 2014-10-15 | 李卫平 | Food with protection effect on lung injury caused by fog and haze |
-
2014
- 2014-12-10 CN CN201410747138.8A patent/CN104605340A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH02265458A (en) * | 1989-04-04 | 1990-10-30 | Nikken Food Kk | Aging control food |
| CN101233893A (en) * | 2007-11-19 | 2008-08-06 | 广东海洋大学 | Method for preparing sargasso ice-cream |
| CN101473983A (en) * | 2008-11-10 | 2009-07-08 | 广东海洋大学 | Method for producing compound beverage with pineapple and gulfweed juices |
| CN101449827A (en) * | 2008-12-29 | 2009-06-10 | 江西品生源生物工程有限责任公司 | Green algae oral liquid production method |
| CN104095182A (en) * | 2014-06-16 | 2014-10-15 | 李卫平 | Food with protection effect on lung injury caused by fog and haze |
Non-Patent Citations (1)
| Title |
|---|
| 胡雅琴等: "国内最近5年藻类的研究进展", 《陕西师范大学学报》 * |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105725194A (en) * | 2016-02-22 | 2016-07-06 | 北京珍生康业生物科技有限公司 | Membrane-ruptured euglena capsules and preparation method thereof |
| CN105725194B (en) * | 2016-02-22 | 2019-06-11 | 北京珍生康业生物科技有限公司 | A kind of rupture of membranes Euglena capsule and preparation method thereof |
| CN105661535A (en) * | 2016-04-11 | 2016-06-15 | 姜国辉 | Lung-moistening and inflammation-diminishing composition for preventing haze harm and preparation method thereof |
| CN105661535B (en) * | 2016-04-11 | 2018-06-19 | 姜国辉 | A kind of composition of the pre- haze harm of moistening lung anti-inflammatory and preparation method thereof |
| CN105901714A (en) * | 2016-04-27 | 2016-08-31 | 青岛旭能生物工程有限责任公司 | Euglena compound tablet and preparation method thereof |
| CN105901573A (en) * | 2016-04-27 | 2016-08-31 | 青岛旭能生物工程有限责任公司 | Nannochloropsis salina oil powder containing capsule and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102919417B (en) | Honey tea and preparation method thereof | |
| CN104605340A (en) | Euglena oral liquid and production method thereof | |
| CN102742904A (en) | Vinegar egg beverage and production method thereof | |
| CN104095182B (en) | A kind of injury of lungs caused haze has the food of protective effect | |
| KR101447231B1 (en) | A manufacturing method of overhang solution pellet and overhang solution pellet munufactured by the same | |
| CN103380833B (en) | One is sobered up fruit tea and preparation method thereof | |
| KR101177786B1 (en) | Method for producing health food containing honeybee pollen fermented solution, propolis, honey and royal jelly | |
| CN105918747A (en) | Wild papaya beverage processing technology | |
| CN102715624A (en) | Natural preservative | |
| CN104587296A (en) | Plant fermented liquid based antibacterial method | |
| CN101869342B (en) | Method for preparing solid beverage comprising branched chain amino acid | |
| CN106107070A (en) | A kind of Chinese herbal medicine feed for goat and preparation method thereof | |
| CN102599500A (en) | Preparation method for starfish oral liquid | |
| CN105851245A (en) | Novel cream preservative | |
| CN104248015A (en) | Health trichosanthes kirilowii maxim juice | |
| CN104012848A (en) | Mantis shrimp healthcare freshness-retaining rice cake and preparation method thereof | |
| KR20140065061A (en) | Herbal medicines using natural antibacterial , anti-inflammatory solution | |
| CN102461571A (en) | Full efficiency mildew inhibitor and preparation method thereof | |
| CN105851550A (en) | Sheep feed synergist for improving stress resistance | |
| CN101467718A (en) | Health type oral preparation and technique for producing the same | |
| KR20160104420A (en) | Manufacturing methods of Pepper fermentation broth | |
| CN104473279A (en) | Hericium erinaceus beverage | |
| CN104187923B (en) | A kind of health drink containing mantis shrimp head, Squilla Oratoria Shell and preparation method thereof | |
| CN103371242A (en) | Tea bag | |
| CN107484829A (en) | A kind of DHA algal oil goat milk piece and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150513 |